Nanobiotix Files 6-K Report
Ticker: NBTX · Form: 6-K · Filed: May 14, 2025 · CIK: 1760854
| Field | Detail |
|---|---|
| Company | Nanobiotix S.A. (NBTX) |
| Form Type | 6-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
Related Tickers: NBTX
TL;DR
Nanobiotix (NBTX) filed a 6-K, standard foreign issuer report.
AI Summary
Nanobiotix S.A. filed a Form 6-K on May 14, 2025, reporting its status as a foreign private issuer. The company, based in Paris, France, is registered with the SEC under file number 001-39777 and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Nanobiotix S.A.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Nanobiotix S.A. (company) — Filer of the 6-K report
- 001-39777 (company) — SEC File Number for Nanobiotix S.A.
- May 14, 2025 (date) — Filing date of the 6-K
- Paris, France (location) — Principal executive office location
FAQ
What type of report is Nanobiotix S.A. filing?
Nanobiotix S.A. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When was this Form 6-K filed?
The Form 6-K was filed on May 14, 2025.
What is Nanobiotix S.A.'s SEC file number?
Nanobiotix S.A.'s SEC file number is 001-39777.
Where is Nanobiotix S.A. located?
Nanobiotix S.A.'s principal executive office is located at 60 Rue de Wattignies, 75012 Paris, France.
Does Nanobiotix S.A. file annual reports under Form 20-F?
Yes, Nanobiotix S.A. indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 14, 2025 regarding Nanobiotix S.A. (NBTX).